Australia’s most read investor-focused magazine for ASX-listed Tech & Biotech stocks
Trending Stories
28 October, 2024
PainChek (ASX: PCK) Advances US Expansion with Positive Validation Study Results for FDA Submission
PainChek Limited (ASX: PCK), a leader in digital pain assessment technology, has cleared a significant milestone in its path to US market entry. Following positive results from a validation study,...
24 October, 2024
Aussie Broadband Starts FY25 Strong with Solid Growth Across Segments and New Partnerships
Aussie Broadband (ASX: ABB) has kicked off FY25 with impressive momentum, as outlined in its 1Q trading update released on 25 October 2024. The company reported significant growth in broadband...
24 October, 2024
RocketDNA Gears Up for Expansion with Strong Q3, Secures Key Contracts Across Mining and Law Enforcement
RocketDNA (ASX: RKT) has delivered an action-packed quarterly report for the three months ending September 2024, bolstered by new contracts, sector diversification, and a focus on autonomous drone...
24 October, 2024
Telix Pharmaceuticals' Brain Cancer Imaging Agent Receives Priority Review from FDA
In a significant milestone for Australian biotech, Telix Pharmaceuticals Limited (ASX: TLX) has announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA)...
24 October, 2024
Memphasys’ Felix™ Clinical Trial Nears Completion as CE Mark Strategy Speeds European Market Entry
Australian biotech company Memphasys Limited (ASX: MEM) is closing in on a key milestone with its Felix™ System clinical trial, which is now 90% complete. With fewer than 20 patients left to recruit,...
Latest News
Latest Web & Podcasts
Book Now for the Next Edition
Reach real investors through TechInvest Magazine, distributed as an independent insert in The Australian Financial Review, online via www.techinvest.online as well as across investor-focused social media channels.
Book now for TechInvest Edition 4, coming in 2024 with many opportunities to showcase your Tech insights.
What you get:
- Article on your company written by a highly experienced writer or supplied by your company
- Approved article included in TechInvest and replicated on www.techinvest.online
- Two page ‘Company in Focus’ features receive prominent pointer on front page of magazine
- Copy of article (copyright free) for you to use for own marketing purposes
- 10 copies of magazine